This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fang, Y. Articles by Nilsen-Hamilton, M. Search for Related Content PubMed PubMed Citation Articles by Fang, Y. Articles by Nilsen-Hamilton, M.

Signaling between the Placenta and the Uterus Involving the Mitogen-Regulated Protein/Proliferins¹

Department of Biochemistry (Y.F., P.L., M.N.-H.), Biophysics and Molecular Biology, Department of Zoology and Genetics (J.T.F., R.T.H.), and Department of Animal Sciences (S.P.F.), Iowa State University, Ames, Iowa 50011

Address all correspondence and requests for reprints to: Marit Nilsen-Hamilton, Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, 3206 Molecular Biology Building, Ames, Iowa 50011. E-mail: marit{at}iastate.edu

The aim of this investigation was to examine signaling between the placenta and uterus during pregnancy. To do this, we determined the tissue messenger RNA and protein levels of members of a glycopeptide hormone family known to stimulate the proliferation of uterine cells and related these levels to the growth of the uterus during pregnancy in the mouse. This hormone family is known as mitogen-regulated protein (MRP); alternatively proliferin (PLF). Three mrp/plf genes, plf1, mrp3 and mrp4, are expressed by the placenta with different developmental profiles. The major increase of about 4-fold in DNA content of the uterus occurs between days 9 and 14 when MRP/PLFs are present in the placenta. By contrast, the gestational changes in estradiol-17ß levels in placental and uterine tissues and in circulation do not correlate with the period of uterine growth. The previously reported mitogenic activity of the MRP/PLFs and their gestational profiles suggest that one or more of these proteins stimulates uterine proliferation during gestation. Evidence is also presented that expression of MRP3 and/or PLF1, but not MRP4, is negatively regulated by feedback from the uterus. Our results are consistent with the hypothesis that MRP/PLFs stimulate uterine proliferation in vivo and that a uterine factor shuts off PLF1 and/or MRP3 synthesis in the latter half of gestation.

This article has been cited by other articles:

				K. A. Longo, J. A. Kennell, M. J. Ochocinska, S. E. Ross, W. S. Wright, and O. A. MacDougald Wnt Signaling Protects 3T3-L1 Preadipocytes from Apoptosis through Induction of Insulin-like Growth Factors J. Biol. Chem., October 4, 2002; 277(41): 38239 - 38244. [Abstract] [Full Text] [PDF]

				D. J. Toft, S. B. Rosenberg, G. Bergers, O. Volpert, and D. I. H. Linzer Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression PNAS, October 16, 2001; (2001) 231364798. [Abstract] [Full Text] [PDF]

				J. T. Fassett and M. Nilsen-Hamilton Mrp3, a Mitogen-Regulated Protein/Proliferin Gene Expressed in Wound Healing and in Hair Follicles Endocrinology, May 1, 2001; 142(5): 2129 - 2137. [Abstract] [Full Text]

				J. T. FASSETT, R. T. HAMILTON, and M. NILSEN-HAMILTON Mrp4, A New Mitogen-Regulated Protein/Proliferin Gene; Unique in this Gene Family for its Expression in the Adult Mouse Tail and Ear Endocrinology, May 1, 2000; 141(5): 1863 - 1871. [Abstract] [Full Text] [PDF]

				D. J. Toft, S. B. Rosenberg, G. Bergers, O. Volpert, and D. I. H. Linzer Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression PNAS, November 6, 2001; 98(23): 13055 - 13059. [Abstract] [Full Text] [PDF]